Evidence map›Paper›PMID 25722226›Full record

ArticleJournal of endocrinological investigation2015

Effects of treatment modalities for Graves' hyperthyroidism on Graves' orbitopathy: a 2015 Italian Society of Endocrinology Consensus Statement.

L Bartalena, P E Macchia, C Marcocci, M Salvi, F Vermiglio

Abstract readConsensus Statement
In one paragraph

Article in Journal of endocrinological investigation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Systemic safety analysis of mycophenolate in Graves' orbitopathy.Journal of endocrinological investigation · 2020
    Pooled it
  2. Pooled it
  3. Article
  4. Thyrotropin receptor antibodies and Graves' orbitopathy.Journal of endocrinological investigation · 2021
    Review
  5. A Clinical Debate: What Is the Therapeutic Choice for Recurrent Graves' Hyperthyroidism?International journal of endocrinology and metabolism · 2020
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Observational
  15. Review
  16. Review
  17. Safety of total thyroid ablation in patients with Graves' orbitopathy.Journal of endocrinological investigation · 2016
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

L BartalenaEndocrine Unit, Department of Clinical and Experimental Medicine, University of Insubria, Ospedale di Circolo, Viale Borri, 57, 21100, Varese, Italy. luigi.bartalena@uninsubria.it.
P E MacchiaDepartment of Clinical Medicine and Surgery, University of Naples "Federico II", Naples, Italy.
C MarcocciDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
M SalviDepartment of Clinical Sciences and Community Health, Graves' Orbitopathy Center, Fondazione Ca' Granda IRCCS and University of Milan, Milan, Italy.
F VermiglioDepartment of Clinical and Experimental Medicine, University of Messina, Messina, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ConsensusGraves DiseaseGraves OphthalmopathyHumansItalyPractice Guidelines as TopicSocieties, MedicalAntithyroid drugsGlucocorticoidsGraves’ diseaseGraves’ orbitopathyRadioiodineThionamidesThyroidectomy

Identifiers

PMID25722226
PMCPMC4374116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.